Back

Long-term antihypertensive effect of renal denervation in resistant hypertension: three years follow-up

28 August 2022 (14:15 - 14:45)
Organised by:
Congress Presentation Part of: Hypertension - Treatment from pharmacotherapy to device and intervention Device Treatment and Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Anna Moiseeva

Institute of Cardiology, Chisinau (Moldova (Republic of))

3 More presentations in this session

Presentation thumbnail
The differential effects of antihypertensive drugs on central blood pressure: nebivolol versus telmisartan (ATD-CBP)
Doctor S. Lim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Device and non-device-guided slow breathing to reduce blood pressure in hypertensive patients: a systematic review and meta-analysis.
Doctor K. De Freitas Goncalves (Ribeirao Preto, BR)
Abstract Slides
Presentation thumbnail
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team
Doctor S. Fezzi (Verona, IT)
Abstract Slides

Access the full session

Session thumbnail
Hypertension - Treatment from pharmacotherapy to device and intervention

The Event

Event poster

ESC Congress 2022

28 August 2022 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Opening: tackling the unmet need in hypertension care
thumbnail
Congress Presentation
State-of-the-art lecture on device-based hypertension management
thumbnail
Congress Presentation
Hot papers on device-based treatment of hypertension

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources